The trademark application SorTabs was filed by VectorY B.V., a corporation established under the laws of the Kingdom of the Netherlands (the "Applicant"). The application was published for oppositions on February 14, 2023, and it was registered by office on May 24, 2023 without any oppositions.
The application was filed in English (German was selected as the second language).
Goods And Services
The mark was filed in class 5 with following description of goods:
Viral systems, gene therapy systems, nucleic acid delivery systems, namely viral vectors, non-viral vectors, gene therapy vectors, nucleic acid delivery vectors, and cells transformed by viral vectors, non-viral vectors, gene therapy vectors or nucleic acid delivery vectors for medical purposes
Pharmaceutical products
Biological preparations for use in medical and clinical gene therapy, nucleic acid-based therapy and cell therapy
Clinical medical reagents for use in nucleic acid-based therapy, gene therapy, cell therapy, gene diagnosis and gene testing
Pharmaceutical preparations, vaccines, prophylaxis products and other pharmaceutical products for use in nucleic acid-based therapy, gene therapy and cell therapy.
The mark was filed in class 42 with Research, product development and consultancy in the field of biotechnology, biologics, medical science, chemistry and biochemistry and Research and product development in the field of pharmaceutics..
The mark was filed in class 44 with Gene and nucleic acid delivery, gene and nucleic acid transfer, gene and nucleic acid regulation and gene and nucleic acid modulation for the treatment of metabolic disorders, ocular disorders, diseases of the nervous system, blood disorders, liver disorders, muscular disorders, muscular skeletal disorders, cancers, infectious diseases, inflammatory and auto-immune diseases, vascular disorders, inherited disorders, genetic disorders and single gene disorders and Consultancy in the field of pharmaceutics..